Classification of chronic hepatitis: Diagnosis, grading and staging

HepatologyVolume 19, Issue 6 p. 1513-1520 Special ArticleFree Access Classification of chronic hepatitis: Diagnosis, grading and staging Prof. Dr. Valeer J. Desmet, Corresponding Author Prof. Dr. Valeer J. Desmet Department of Pathology, Catholic University of Leuven, Leuven, BelgiumUniversitair Ziekenhuis Sint Rafaël, Laboratorium voor Histo- & Cytochemistry, Minderbroedersstraat 12, B-3000 Leuven, Belgium===Search for more papers by this authorMichael Gerber, Michael Gerber Department of Pathology, Tulane University, New Orleans, LouisianaSearch for more papers by this authorJay H. Hoofnagle, Jay H. Hoofnagle Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MarylandSearch for more papers by this authorMichael Manns, Michael Manns Department of Gastroenterology and Hepatology, Zentrum Innere Medizin, Medical School of Hannover, Hannover, GermanySearch for more papers by this authorPeter J. Scheuer, Peter J. Scheuer Department of Histopathology, Royal Free Hospital and School of Medicine, London, United KingdomSearch for more papers by this author Prof. Dr. Valeer J. Desmet, Corresponding Author Prof. Dr. Valeer J. Desmet Department of Pathology, Catholic University of Leuven, Leuven, BelgiumUniversitair Ziekenhuis Sint Rafaël, Laboratorium voor Histo- & Cytochemistry, Minderbroedersstraat 12, B-3000 Leuven, Belgium===Search for more papers by this authorMichael Gerber, Michael Gerber Department of Pathology, Tulane University, New Orleans, LouisianaSearch for more papers by this authorJay H. Hoofnagle, Jay H. Hoofnagle Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MarylandSearch for more papers by this authorMichael Manns, Michael Manns Department of Gastroenterology and Hepatology, Zentrum Innere Medizin, Medical School of Hannover, Hannover, GermanySearch for more papers by this authorPeter J. Scheuer, Peter J. Scheuer Department of Histopathology, Royal Free Hospital and School of Medicine, London, United KingdomSearch for more papers by this author First published: June 1994 https://doi.org/10.1002/hep.1840190629Citations: 1,778AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, Scheuer PJ, et al. A classification of chronic hepatitis. Lancet 1968; 2: 626–628. 2 Mackay IR, Taft LI, Cowling DC. Lupoid hepatitis. Lancet 1956; 2: 1323–1330. 3 Ludwig J. The nomenclature of chronic active hepatitis: an obituary. Gastroenterology 1993; 105: 274–278. 4 Boyer JL, Klatskin G. Pattern of necrosis in acute viral hepatitis: prognostic value of bridging (subacute hepatic necrosis). N Engl J Med 1970; 283: 1063–1071. 5 Popper H, Schaffner F. The vocabulary of chronic hepatitis. N Engl J Med 1971; 284: 1154–1157. 6 Bianchi L, De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, et al. Acute and chronic hepatitis revisited. Lancet 1977; 2: 914–919. 7 Popper H. Changing concepts of the evolution of chronic hepatitis and the role of piecemeal necrosis. Hepatology 1983; 3: 758–762. 8 Leevy CM, Popper H, Sherlock S. Diseases of the liver and biliary tract. Standardization of nomenclature, diagnostic criteria, and diagnostic methodology. Washington, D.C.: U.S. Government Printing Office, 1976: DHEW publication no (NIH)76–725. (Fogarty International Center Proceeding, no. 22). 9 Davis GL, Ballart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, et al. Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomized controlled trial. N Engl J Med 1989; 321: 1501–1505. 10 Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC, Lindsay K, Payne J, Dienstag JL, et al. A randomized controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990; 323: 295–301. 11 Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991; 14: 969–974. 12 Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transsection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646–649. 13 de Jongh FE, Janssens HLA, de Man RA, Hop WCJ, Schalm SW, van Blankenstein M. Survival and prognostic indicators in HBsAg-positive cirrhosis of the liver: the role of HBeAg serocon-version. Gastroenterology 1992; 103: 1630–1635. 14 Hoofnagle JH, Di Bisceglie AM, Waggoner JG, Park Y. Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B. Gastroenterology 1993; 104: 1116–1121. 15 Brunetto MR, Stemler M, Schodel F, Will H, Ottobrelli A, Rizzetto M, Verme G, et al. Identification of HBV variants which cannot produce precore derived HBeAg and may be responsible for severe hepatitis. Ital J Gastroenterol 1989; 21: 151–154. 16 Carman WF, Jacyna MR, Hadziyannis S, Karayannis P, McGarvey MI, Makris A, Thomas HC. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989; 2: 588–591. 17 Lenzi M, Ballardini G, Fusconi M, Cassani S, Selleri L, Volta U, Zauli D, et al. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 1990; 335: 258–259. 18 Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest 1991; 88: 1370–1378. 19 Lunel F, Abuaf N, Grangeul L, Grippon P, Le Coz Y, Valla D, Borotto E, et al. Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology 1992; 16: 630–636. 20 Michel G, Ritter A, Gerken G, Meyer zum Büschenfelde K-H, Decker R, Manns MP. Anti-GOR and hepatitis C virus in autoimmune liver disease. Lancet 1992; 339: 267–269. 21 Vergani D, Mieli-Vergani G. Type II autoimmune hepatitis: what is the role of hepatitis C virus. Gastroenterology 1993; 104: 1870–1873. 22 Rizzetto M, Canese MG, Arico S, Crivelli O, Trepo C, Bonino F, Verme G. Immunofluorescense detection of a new antigen-antibody system (delta/anti-delta) associated with hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977; 18: 997–1003. 23 Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, Poupon R, et al. Chronic active hepatitis associated with anti-liver/kidney microsome antibody type I: a second type of “autoimmune hepatitis.” Hepatology 1987; 7: 1333–1339. 24 Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Büschenfelde K-H. Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1987; 1: 292–294. 25 Johnson PJ, McFarlane IG. Meeting report: international autoimmune hepatitis group. Hepatology 1993; 18: 998–1005. 26 Berg PA, Wiedmann KH, Sayers T, Klöppel G, Lindner H. Serological classification of chronic cholestatic liver disease by the use of two different types of antimitochondrial antibodies. Lancet 1980; 2: 1329–1332. 27 Davis P, Leung P, Manns M, Kaplan M, Munoz S, Gorin F, Dickson R, et al. M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena. Hepatology 1992; 16: 1128–1136. 28 Palmer JM, Yeaman SJ, Bassendine MF, James OFW. M4 and M9 autoantigens in primary biliary cirrhosis: a negative study. J Hepatol 1993; 18: 251–254. 29 Klein R, Berg PA. Anti-M4 antibodies in primary biliary cirrhosis react with sulphite oxidase, an enzyme of the mitochondrial inter-membrane space. Clin Exp Immunol 1991; 84: 445–448. 30 Brunner G, Klinge O. Ein der chronisch-destruierenden nichteitrigen Cholangitis ähnliches Krankheitsbild mit antinukleären Antikörpern (Immunocholangitis). Dtsch Med Wochenschr 1987; 112: 1454–1458. 31 Ben Ari Z, Dhillon AP, Sherlock S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology 1993; 18: 10–15. 32 Rabinovitz M, Demetris AJ, Bou-Abboud CF, Van Thiel DH. Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis. Dig Dis Sci 1992; 37: 1606–1611. 33 Beaune PH, Dansette PM, Mansuy D, Kiffel L, Finck M, Amar C, Leroux GP, et al. Human antiendoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P450 that hydroxylates the drug. Proc Natl Acad Sci USA 1987; 84: 551–555. 34 Bourdi M, Larrey D, Nataf J, Bernuau J, Pessayre D, Iwasaki M, Guengerich FP, et al. Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P450IA2. J Clin Invest 1990; 85: 1967–1973. 35 Stricker BHCh. Drug-induced hepati. Injury. 2nd ed. Amsterdam: Elsevier, 1992: 550. 36 Jeffers J, Hasan F, de Medina M, Reddy R, Parker T, Silva M, Mendez L, et al. Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis. Hepatology 1992; 15: 187–190. 37 Czaja AJ, Carpenter HA, Santrach PJ, Moore SB, Homburger HA. The nature and prognosis of severe cryptogenic chronic active hepatitis. Gastroenterology 1993; 104: 1755–1761. 38 Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431–435. 39 Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13: 372–374. 40 Cooksley WGE, Bradbear RA, Robinson W, Harrison M, Halliday JW, Powell LW, Ng HS, et al. The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis. Hepatology 1986; 6: 345–348. 41 Popper H. Pathologic aspects of cirrhosis. Am J Pathol 1977; 87: 228–264. 42 Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH. The morphology of cirrhosis: recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol 1978; 31: 395–414. 43 Gerber MA, Thung SN. Cell lineage studies in human liver regeneration, proliferation and transformation. In: AE Sirica, ed. The role of cell types in hepatocarcinogenesis. Boca Raton, FL: CRC Press, 1992: 209–226. Citing Literature Volume19, Issue6June 1994Pages 1513-1520 ReferencesRelatedInformation